PMID: Summary Keywords biologic therapy, early psoriatic arthritis, GLP-1 receptor agonists, inflammation, metabolic syndrome, psoriasis Citation Ciancio G, Maranini B, Sandri G, Amati G, Bortoluzzi A, Silvagni E, Govoni M and Giuggioli D (2026) Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities
If you are struggling with hypoglycemia after starting semaglutide, talk with your doctor
Weight loss results vary by individual
pdfFiller is not affiliated with any government organization Fill out Complete the form online in a simple drag-and-drop editor
The filing includes claims directed to potential use of the microorganism to preserve lean muscle mass in a human patient, including embodiments involving lactic acid bacteria such as Lactobacillus paracasei
Synergistic Action When GLP-1, GIP, and glucagon receptors are simultaneously activated, their effects are synergistic